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Background: Perioperative fluid therapy remains a highly debated topic. Its purpose is to maintain or restore
effective circulating blood volume during the immediate perioperative period. Maintaining effective circulating
blood volume and pressure are key components of assuring adequate organ perfusion while avoiding the risks
associated with either organ hypo- or hyperperfusion. Relative to perioperative fluid therapy, three inescapable
conclusions exist: overhydration is bad, underhydration is bad, and what we assume about the fluid status of our
patients may be incorrect. There is wide variability of practice, both between individuals and institutions. The aims
of this paper are to clearly define the risks and benefits of fluid choices within the perioperative space, to describe
current evidence-based methodologies for their administration, and ultimately to reduce the variability with which
perioperative fluids are administered.
Methods: Based on the abovementioned acknowledgements, a group of 72 researchers, well known within the
field of fluid resuscitation, were invited, via email, to attend a meeting that was held in Chicago in 2011 to discuss
perioperative fluid therapy. From the 72 invitees, 14 researchers representing 7 countries attended, and thus, the
international Fluid Optimization Group (FOG) came into existence. These researches, working collaboratively, have
reviewed the data from 162 different fluid resuscitation papers including both operative and intensive care unit
populations. This manuscript is the result of 3 years of evidence-based, discussions, analysis, and synthesis of the
currently known risks and benefits of individual fluids and the best methods for administering them.
Results: The results of this review paper provide an overview of the components of an effective perioperative fluid
administration plan and address both the physiologic principles and outcomes of fluid administration.
Conclusions: We recommend that both perioperative fluid choice and therapy be individualized. Patients should
receive fluid therapy guided by predefined physiologic targets. Specifically, fluids should be administered when
patients require augmentation of their perfusion and are also volume responsive. This paper provides a general
approach to fluid therapy and practical recommendations.
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Fluid therapy is important
Major surgery is a considerable physiologic insult that
can be associated with significant morbidity and mortality.
The occurrence of one or more postoperative complica-
tions adversely effects both short-term and long-term sur-
vival and increases healthcare costs [1,2]. The prevention
of postoperative morbidity is a key factor in providing
high-quality, high-value health care.
Perioperative fluid management remains a highly de-
bated topic. There is wide variability of practice, both
between individuals and institutions. Perioperative morbid-
ity is linked to the amount of intravenous fluid adminis-
tered (fluid therapy) with both insufficient and, more
commonly, excess fluid delivery leading to increased post-
operative complications [3-5]. Currently taught and prac-
ticed methods of intraoperative volume management in
which intravenous fluids are given based on a generalizable
formula relying on body weight per unit time and modified
by the perceived magnitude of surgical ‘trauma’ [6] are not
supported by known physiologic principles. Fluid therapy
should be considered when patients are both in need of en-
hanced blood flow and are fluid responsive.
Multiple studies have shown that approaching fluid
therapy with the goal of hemodynamic stabilization can
reduce complications after major surgery [7-9]. More com-
pelling are several meta-analyses and quantitative reviews
demonstrating the strength of these beneficial effects
across patient groups and surgical procedures [8,10]. It
is the purpose of this review to provide an overview of
the components of an effective perioperative fluid ad-
ministration plan.
The physiologic principles of fluid support
A patient’s physiologic status in general and hemodynamic
stability in particular define the need for cardiovascular
support, including fluid therapy and use of vasoactive
drugs (vasopressors, vasodilators) and inotropes. Specific
hemodynamic goals include maintaining adequate blood
volume and sustaining perfusion pressure so as to maintain
cardiac output, tissue blood flow, and adequate oxygen de-
livery. Fluid therapy is often the first line of hemodynamic
support because decreased effective circulating blood vol-
ume often accompanies induction of anesthesia and surgi-
cal trauma. However, fluid therapy only indirectly impacts
cardiac and vascular function. Optimizing oxygen deliv-
ery and assuring the removal of metabolic bioproducts
may require a combination of individualized fluid ther-
apy, pharmacotherapy, and occasionally mechanical car-
diovascular support.
Fluid infusions directly increase vascular volume, subse-
quently and usually improve global and regional perfusion
and blood pressures if the heart is preload-responsive, and
often improve oxygen delivery and tissue oxygenation.However, these changes are profoundly influenced by the
cardiac and peripheral vascular status [11]. Thus, the same
fluid therapy can have profoundly different and occa-
sionally opposite changes in cardiovascular state. For
this reason, the blind infusion of fluids or the use of
vasopressors without first understanding the patient’s
cardiovascular reserve is discouraged. Given these physio-
logic principles, hemodynamic optimization requires that
the anesthesiologist consider three specific therapies for
each patient: 1) fluid therapy for the correction of volume
deficits associated with insufficient circulating blood vol-
ume and oxygen delivery, 2) vasopressors and vasodilators
for arterial pressure and vascular tone, and 3) inotropic
support when cardiac output remains inadequate despite
optimization of volume (Figure 1).
Intravenous infusion of fluid directly expands plasma
volume with transient or sustained effect that varies
based on the colloid osmotic properties of the fluid,
blood flow distribution, type and level of anesthesia, vas-
cular endothelial integrity, and the physiologic state. The
expansion of plasma volume causes the mean systemic
pressure to increase, and, if greater than right atrial pres-
sure, the pressure gradient for venous return will increase.
If the right and left ventricle are volume responsive, then
cardiac output will also increase. There is no easy means
to measure plasma volume nor is there a defined means of
how measured plasma volume could be used to achieve
the physiologic goals of optimal pressure, flow, and oxy-
genation for the perioperative patient. Although one can
estimate mean systemic filling pressure in appropriately
instrumented patients, it is unclear if such measures will
alter either therapy or outcome, because knowing plasma
volume and even effective circulating blood volume only
gives a partial picture of the determinants of cardiac out-
put. Other critical factors include blood flow distribution,
vasomotor tone, right ventricular function, and the level
of positive-end expiratory pressure, which, individually
and collectively, may alter cardiovascular responsiveness.
Given the absence of easily obtainable regional measures
of perfusion, the anesthesiologist may consider assessing
global perfusion by measuring base deficit, lactate, and
central and mixed venous oxygen saturation to clarify the
impact of selected interventions.
Perioperative assessment of changes in blood volume
is difficult and requires evaluation of several clinical and
physiologic events that accompany major surgery. Stand-
ard hemodynamic monitoring devices fail to detect occult
hypovolemia [12], which occurs frequently during surgery
and contributes to inadequate tissue perfusion and the
development of postoperative complications. Severely
compromised patients may be identified by the presence
of hypotension; however, not all patients in shock are
hypotensive, and if one waits for hypotension, tissue hypo-
perfusion has already occurred [13]. For example, studies
Figure 1 Perspective of the anesthesiologist’s tools (fluid and drugs) and the physiologic targets of these tools (blood volume,
the heart, and blood vessels). The heart has two components (contractility and rate), and the blood vessels have two major characteristics
(compliance and resistance). It is blood volume, heart, and blood vessels that produce pressure, flow, and oxygen delivery, while the intermediate
physiologic functions and their metrics provide a means of assessing the cardiovascular state and how effective fluids are likely to be.
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of 20% to 30% may occur with minimal change in blood
pressure despite measurable impairment of tissue perfu-
sion [14]. Moreover, hypotension should not serve as an
automatic trigger for fluid administration since not all
hypotensive events are due to hypovolemia.
Tachycardia is considered a classic sign of hypovol-
emia, but the assessment of intravascular volume based
on heart rate lacks sensitivity and specificity [15] for a
variety of reasons, not minimally because of the com-
mon use of beta-adrenergic receptor blocking agents in
older surgical patients.
Perioperative hypovolemia is deleterious to organ func-
tion because normal adaptive mechanisms cause peripheral
vasoconstriction to sustain blood flow to the heart and
brain, causing ischemia to other organ and surgical tissues
in need of blood flow for repair. For surgical patients,
several factors including preoperative fasting, hypertonic
bowel preparations, anesthetic agents, and positive pres-
sure ventilation all contribute to reduced effective circulat-
ing blood volume. Anesthetized patients often present with
a functional intravascular volume deficit [7]. On the other
hand, large volumes of intravenous fluid may cause com-
plications due to the formation of tissue edema. Liberal
administration of fluid may impair pulmonary, cardiac,
gastrointestinal, and renal function, contributing to postop-
erative complications and prolonged recovery [5,16-20].Establishing what constitutes a restrictive or liberal
amount of fluid from the literature is difficult because
the absolute amounts of fluid administered vary substan-
tially among trials making any conclusion difficult to
implement in clinical practice [21]. Several studies have
shown that the absolute amount of perioperative fluid
administered may not be a major determinant of peri-
operative outcomes. Titration of fluid according to a
hemodynamic goal is pivotal in improving perioperative
outcomes [22]. In some studies, improved outcomes have
been reported when set guidelines of ‘restrictive’ or ‘lim-
ited’ fluid therapy have been compared to standard care
for GI surgeries [23-25] and in patients with pulmonary
dysfunction [26,27]. These studies would seem to speak
against individualized goal-directed therapy that is predi-
cated upon optimizing intravascular volume. However,
most certainly, the restrictive fluid studies and the goal-
directed therapy (GDT) trials both make a strong case for
having an a priori perioperative fluid plan. Taken as a
whole, the success of both GDT and of some restrictive
fluid strategies suggests that perioperative fluid planning
must emphasize that fluid therapy be administered only
with clear indication. Functional hemodynamic parame-
ters offer unique information about fluid responsiveness,
which my help detect fluid needs and avoid unnecessary
fluid loading. Despite their limitations and confounding
factors, this information may be crucial in guiding fluid
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target values for the restoration and optimization of circu-
lating volume, pressure, and perfusion must be deter-
mined for each patient.
Perioperative goal-directed therapy impacts clinical
outcomes
Individual clinical trials and meta-analyses have shown
that different fluid therapy regimens produce signifi-
cantly different clinical outcomes and have resulted in
considerable controversy as to the best approach. Table 1
lists trials of GDT trials applied within the perioperative
space [23,29-59]. Most of these studies report higher rates
of complications within the control groups. In high-risk
surgical patients, perioperative fluid overload is associated
with life-threatening complications, including pulmonary
edema and death [60,61]. Interestingly, the application of
specific GDT protocols has often been associated with in-
creased delivery of fluids, especially colloids (Table 1), and
in some studies less. Taken together, these data suggest
that the benefit of fluid therapy is not primarily related to
the volume infused, but rather how and when volume
therapy is administered to a given patient.
The use of standardized fluid therapy protocols within
the perioperative space is limited despite strong evidence
of benefit. A survey by Cannesson et al. compared the fluid
therapy practices of both American Society of Anesthesiol-
ogists (ASA) and European Society of Anesthesiology
(ESA) members [62]. Standardized fluid therapy is sparsely
practiced in the US with less than 6% of ASA respondents
having a facility-based written protocol while ESA mem-
bers were five times more likely to have one.
Lack of standard criteria for fluid therapy results in
significant clinical variability relative to the type and vol-
ume of fluid administered. This variability is linked to
variable outcomes and makes it difficult to assess the
effectiveness of different approaches [21,63]. A universal
formula for an effective fluid management is fraught
with difficulty because responses to fluid therapy vary
widely between patients and not all patients benefit from
fluids [64]. The complexity and individual variability of
human physiology, presurgical morbidities, and the impact
of different surgical procedures makes it easy to under-
stand why a general, one-size-fits-all formula for fluid ad-
ministration is unlikely to provide benefit.
Methods
Based on the abovementioned acknowledgements, a group
of 72 researchers, well known within the field of fluid re-
suscitation, were invited, via email, to attend a meeting that
was held in Chicago in 2011 to discuss perioperative fluid
therapy. From the 72 invitees, 14 researchers representing
7 countries attended, and thus, the international Fluid
Optimization Group (FOG) came into existence. Theseresearches, working collaboratively, have reviewed the data
from 162 different fluid resuscitation papers including both
operative and intensive care unit populations.
IRB
There was no human research involved with this
manuscript.
Results
This manuscript is the result of 3 years of evidence-based,
discussions, analysis, and synthesis of the currently known
risks and benefits of individual fluids and the best methods
for administering them. The results of this review paper
provide an overview of the components of an effective
perioperative fluid administration plan and address
both the physiologic principles and outcomes of fluid
administration.
We present our evidence-based suggestions and individ-
ualized algorithms for a standardized approach to peri-
operative volume therapy for surgical patients. We propose
specific recommendations for fluid administration which
are organized into seven tenets as follows: 1) fluid respon-
siveness, dynamic indices, and the gray zone; 2) consider-
ations of the composition of crystalloids and colloids;
3) evidence-based guidelines and individualized algorithms;
4) perioperative fluid plan; 5) goal-directed therapy; 6) the
fluid challenge; and 7) maintenance fluids.
Recommendations are italicized.
Discussion
Recommendations
Fluid responsiveness, dynamic indices, and the gray zone
In patients who have cardiac rhythms with regular R-R in-
tervals and who are receiving controlled mechanical venti-
lation with tidal volumes between 8 and 10 ml/kg, fluid
responsiveness is most effectively assessed using dynamic
indices. These should be measured in a uniform manner
before and promptly after each fluid intervention [65-69].
Currently used dynamic indices include systolic pressure
variation (SPV), pulse pressure variation (PPV), stroke
volume variation (SVV), and plethysmographic waveform
variation (PWV). The clinical utility of dynamic parame-
ters is limited by many confounding factors that must be
clearly understood by the clinician utilizing them [70].
The role of echocardiography, both transthoracic and
transesophageal, can be critical when evaluating both fluid
responsiveness and cardiac function. In addition, echocar-
diography is of particular use when assessing volume re-
sponsiveness in patients undergoing open chest surgery
where the predictive ability of dynamic indices is also re-
duced [71].
Static parameters (for example, right or left ventricular
diastolic diameter) derived from transesophagic echocar-
diography (TEE) monitoring are not useful in predicting
Table 1 Trials of goal-directed therapy [23,29-59]
Protocols Fluids GDT
versus control
Population GDT endpoints GDT therapy Control protocol Crystalloids Colloids Outcomes GDT versus
control
Reference
Elective cardiac
surgery
ΔSV < 10% (esophageal
Doppler)
Bolus 200 ml colloid Standard of care Less More Reduction of gut mucosal
hypoperfusion, less
postoperative
complications, shorter ICU
stay, shorter HLOS
Mythen and Webb [29]
ΔCVP < 3 mmHg
Proximal femoral
fracture repair
FTc > 400 ms, ΔSV < 10%
(esophageal Doppler)
Bolus 3 ml/kg colloid Standard of care Similar More Shorter HLOS Sinclair et al. [30]
Transthoracic
esophagectomy
CVP < 5 mmHg Restrictive regimen Standard of care No data No data Less postoperative
pulmonary complications
Kita et al. [31]
Major bowel surgery FTc > 350 ms Bolus 3 ml/kg colloid Standard of care No data More Less critical care
admission
Conway et al. [32]
ΔSV < 10% (Doppler)
Major elective surgery FTc > 350 ms Bolus 200 ml colloid Standard of care (HR,
CVP, MAP, UO)
Similar More Less PONV, earlier oral
solid intake, shorter HLOS
Gan et al. [33]
ΔSV < 10% (Doppler)
Proximal femoral
fracture repair
Doppler - FTc > 400 ms, Bolus 200 ml colloid Standard of care
(without CVP or
Doppler)
Similar More Less intraoperative
hypotension, sooner
medically fit for discharge
Venn et al. [34]
ΔSV < 10%
CVP - ΔCVP < 5 mmHg
Elective colorectal
resection
Maintaining preoperative
body weight
Restrictive regimen Standard of care Less Similar Less postoperative
complications (tissue
healing, cardiopulmonary)
Brandstrup et al. [35]
High-risk surgical
patients (≥60 years
old)
DO2 = 550 to 600 ml/
min/m2
Fluids, inotropes,
vasodilators,
vasopressors, RBC
Standard of care
(without PAC)
No data No data More pulmonary
embolism
Sandham et al. [36]
CI = 3.5 to 4.5 l/min/m2
MAP = 70 mmHg
HR < 120 bpm, Ht≥ 27%
Colorectal resection ΔSV < 10% (Doppler) Bolus 250 ml colloid Routine monitoring
(CVP = 12 to
15 mmHg)
Similar More Shorter recovery of gut
function, less morbidity,
shorter HLOS
Wakeling et al. [37]
ΔCVP < 3 mmHg
Elective colorectal
resection
FTc > 350 ms 7 ml/kg first bolus
colloid, then bolus
3 ml/kg colloid
Standard of care
(without bolus)
Similar Similar Less inotrope use, earlier
diet, less days to
medically fit, shorter
HLOS
Noblett et al. [38]
ΔSV < 10% (Doppler)
Low-risk patients
off-pump coronary
surgery
PAC No data Standard of care (CVP) No data No data More use of inotropes Resano et al. [39]
Major abdominal
surgery
O2ER < 27% Colloid bolus, RBC,
dobutamine
Standard of care
(MAP, UO)
No data No data Less organ failure, shorter
HLOS
Donati et al. [40]
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Table 1 Trials of goal-directed therapy [23,29-59] (Continued)
Cardiac bypass
surgery
GEDVI = 640 ml/m2 Bolus 500 ml,
vasopressors
Standard of care (CVP,
MAP, clinical
evaluation)
Similar More Shorter and reduced
need for vasopressors,
mechanical ventilation,
and ICU therapy
Goepfert et al. [41]
CI > 2.5 l/min/m2
MAP = 70 mmHg
High-risk surgery ΔPP < 10% Bolus colloid Standard of care Similar More Less postoperative
complications, shorter
time of mechanical
ventilation, ICU stay and
HLOS
Lopes et al. [42]
Moderate to high-risk
cardiac surgery
DO2 = 450 to 600 ml/
min/m2
Bolus 100 ml colloid CVP = 6 to 8 mmHg Similar More Lower number of
adjustments of inotropic
agents
Kapoor et al. [43]
CI = 2.5 to 4.2 l/min/m2 MAP = 90 to
105 mmHg
SVI = 30 to 65 ml/beat/m2 UO > 1 ml/kg/h
ScvO2 > 70%, SVV < 10%
Off-pump coronary
surgery
ITBVI > 850 ml/m2 Bolus 500 ml colloid Standard of care
(MAP, CVP, HR)
Similar More Shorter HLOS Smetkin et al. [44]
ScvO2 > 60%
Laparoscopic
segmental colectomy
2 GDT groups: Bolus 200 ml colloid
or 300 ml crystalloid
Standard of care More (GDT
crystalloid)
More (GDT
colloid)
More postoperative
complications on group
GDT colloid
Senagore et al. [45]
ΔSV < 10%
Crystalloids versus colloids
Major abdominal
surgery
PVI < 13% Bolus 250 ml colloid
(norepinephrine to
MAP > 65 mmHg)
Standard of care
(MAP, CVP)
Less Similar Lower lactate levels Forget et al. [46]
Elective surgery for GI
malignancy
Serum lactate <
1.6 mmol/l
Bolus 250 to 1,000 ml
colloid (depending
serum lactate)
Restrictive regimen Similar Similar Less systemic
complications in patients
that need postoperative
supplementary fluids
Wenkui et al., [47]
Major abdominal
surgery
Peak aortic flow velocity
< 13% (Doppler)
Bolus 250 ml,
vasopressors,
dobutamine,
restrictive crystalloids
Standard of care
(12 ml/kg/h
crystalloids)
Less (patients
with complication)
More (patients with
complication)
More postoperative
complications
Futier et al. [48]
Peripheral artery
bypass grafting
CI > 2.5 l/min/m Bolus 250 ml colloid,
dobutamine
Standard of care
(MAP, CVP)
No data Similar No difference between
groups
Van der Linden
et al. [49]
Major abdominal
surgery
CI > 2.5 l/min/m2 Bolus 500 ml
crystalloid, bolus
250 ml colloid,
dobutamine,
norepinephrine
Standard of care
(MAP, CVP, UO)
Less More Less postoperative
complications, shorter
HLOS
Mayer et al. [50]
SVI > 35 ml/beat/m2
MAP > 65 mmHg
Elective intra-
abdominal surgery in
high-risk patients
SVV < 10% Bolus 3 ml/kg colloid,
dobutamine
Standard of care
(MAP > 65 mmHg, HR
< 100 bpm, CVP = 8
to 15 mmHg, UO >
0.5 ml/kg/h)
Similar More Better intraoperative
hemodynamic stability,
lower serum lactate, less
postoperative
complications
Benes et al. [51]
CI > 2.5 l/min/m2
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Table 1 Trials of goal-directed therapy [23,29-59] (Continued)
Elective total hip
replacement
DO2 > 600 ml/min/m
2 Bolus 250 ml colloid,
dobutamine, RBC
Standard of care
(MAP)
More More Less postoperative
complications,
(hypotension,
cardiovascular)
Cecconi et al. [52]
ΔSV < 10%, Hb > 10 g/dl
Elective colorectal
surgery
ΔSV < 10% Bolus 200 ml colloid Zero balance
intraoperative fluids
(MAP > 60 mmHg)
Similar More No difference between
groups
Brandstrup et al. [23]
Major abdominal
surgery (cirrhotic
patients)
2 GDT groups: Bolus 250 ml LR
followed by 3 ml/kg
colloid
Same for both groups Similar Similar No difference between
groups
Abdullah et al. [53]
PVI < 13%
FTc > 350 ms
Major colorectal
surgery
ΔSV < 10% Bolus 200 ml colloid Standard of care Similar More More blood loss and
need for transfusion in
OR, longer HLOS
Challand et al. [54]
Noncardiac major
surgery
FTc > 300 ms, ΔSV < 10% Bolus 200 ml colloid Bolus 200 ml
crystalloid
Less More Less transfusion of FFP,
better hemodynamic
stability
Feldheiser et al. [55]
MAP > 70 mmHg
CI > 2.5 l/min/m2
Elective colectomy FTc > 400 ms 7 ml/kg first bolus
colloid, then bolus
3 ml/kg colloid
Restrictive regimen Similar More No differences in
outcomes
Srinivasa et al. [56]
ΔSV < 10% (HR, MAP, UO)
Cytoreductive surgery
(ovarian cancer)
ΔSV < 10% Bolus 200 ml 200 ml crystalloid Less More Better hemodynamic
stability, less FFP
transfusion
Feldheiser et al. [57]
Major abdominal
surgery
CI > 2.5 l/min/m2 Fluids, dobutamine,
vasopressors
Standard of care Similar Similar Less postoperative
complications, lower
infection rate
Salzwedel et al. [58]
PPV < 10%
MAP > 65 mmHg
Major abdominal
surgery
CO SV Bolus 250 ml colloid Standard of care (CVP) Less More No difference in
outcomes
Pearse et al. [59]
Individual clinical trials and meta-analyses have shown that different fluid therapy regimens produce significantly different clinical outcomes and have resulted in considerable controversy as to the best approach. This
table represents a summary of the known peer-reviewed GDT trials including their physiologic targets, fluids used, and outcomes measured.
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derived dynamic indices such as delta IVC and delta SVC
diameter during positive pressure ventilation have shown
to be effective for evaluating fluid responsiveness [73]. As
with all echocardiographic techniques, image acquisition
and interpretation requires considerable education and ex-
perience. Furthermore, equipment expense still remains a
considerable barrier to widespread implementation.
While dynamic indices are excellent for predicting vol-
ume responsiveness, measured changes in cardiac output
(ΔCO) or stroke volume (ΔSV) may be required to as-
sure the effectiveness of a fluid bolus [74,75]. Dynamic
indices can be used to predict when fluid therapy could
be administered and when its administration should be
stopped. Bolus volume therapy should be discontinued
when a patient reaches that point on their Frank-Starling
curve where further volume therapy will not augment
cardiac stroke volume (dynamic index < 10%, ΔSV or
ΔCO < 10%).
Dynamic indices have been repeatedly shown to accur-
ately reflect fluid responsiveness and do so better than
commonly used static hemodynamic parameters. These
parameters have been validated and used to guide fluid
therapy in a variety of surgical patients, including those
undergoing major abdominal [42,50,68,76-78], cardiac
[69,79-86], neurosurgical [87,88], and vascular surgery [89].
Static measures such as central venous pressure (CVP)
may be invaluable during patient care [90]; however, CVP
is not useful as a predictor of volume responsiveness.
Dynamic parameters should be an integral part of GDT
protocols for those patients in which they can be accur-
ately measured. ΔCO or ΔSV can be used in the remaining
patients. Not taking into account the status of fluid re-
sponsiveness when making fluid therapy decisions is
bound to result in unjustified fluid administration even
when GDT is being used. In addition, dynamic parameters
may precede continuously measured CO, heart rate, and
blood pressure in alerting to the development of hypovol-
emia and may therefore trigger an early and justified fluid
administration [91,92]. It is important to realize, however,
that the presence of fluid responsiveness is not an absolute
indication to give fluids. The decision to administer fluid
therapy must be supported by proof of volume responsive-
ness, the need for hemodynamic improvement, and the
lack of associated risk [93]. Fluid load per se is not always
the correct therapy for hemodynamic instability.
The predictive ability of various dynamic indices has
been compared in a number of studies. PPV had been
found to be somewhat more accurate than the SPV and
SVV [79,94,95]. However, it is difficult to determine a sin-
gle cutoff point to predict fluid responsiveness. Cannesson
et al. showed that, despite strong predictive value, there is
a range of PPV values, named the gray zone (between 9%
and 13%), for which fluid responsiveness cannot bereliably predicted in 25% of patients during general
anesthesia [93]. Moreover, the gray zone limits may
change according to the fluid management strategy to
be applied [93]. Thus, when PPV enters the gray zone,
uncertainty exists and clinicians should utilize other
tools to assess fluid responsiveness. Furthermore, the
range applied to PPV may not be applicable when SVV
or other dynamic indices are used for determining volume
responsiveness. The gray zone for each dynamic index re-
quires its own definition [96].
The interaction between PPV and SVV (PPV/SVV)
has also been studied as a measure of dynamic vascular
compliance [97,98]. These combined parameters may be
used to identify those hypotensive patients who have an
underlying vasodilatory component to their hypotensive
state and, thus, the need for vasopressor therapy [99].
Since pulse oximetry is a standard noninvasive intra-
operative monitor, the respiratory variation in the ple-
thysmographic waveform (PWV) is potentially the most
commonly available dynamic parameter in mechanically
ventilated anesthetized patients [100]. The major problem
with the clinical use of PWV is the significant impact of
vasoconstriction (for example, hypotension, hypothermia)
on the plethysmographic waveform. However, an in-
crease in the PWV may be the first sign of the develop-
ment of a still-occult hypovolemia and should prompt
the anesthesiologist to consider the immediate adminis-
tration of fluids.
Limitations of dynamic indices Fluid responsiveness
measures cannot be used in all patients and at all times
in many patients. Dynamic indices have a high predictive
value in determining fluid responsiveness; however, spe-
cific criteria must be met in order to use these indices to
assess fluid responsiveness. Intraoperative motion, elec-
trosurgical equipment, and physiologic artifact (noise)
can interfere with the accurate interpretation of dynamic
indices. Four primary limitations may exist in the use of
dynamic indices. First, arrhythmias (for example, atrial
fibrillation) preclude the use of SPV, PPV, SVV, and PWV
to predict volume responsiveness, while inferior and su-
perior vena cava variability remain accurate. The same
limitation of SPV, PPV, SVV, and PWV is seen in subjects
having varying levels of spontaneous inspiratory efforts.
Again, inferior vena and superior vena cava diameter vari-
ability may remain predictive of volume responsiveness
during spontaneous breathing. Second, if tidal volumes
are <8 ml/kg, then the negative predictive value of SPV,
PPV, SVV, and PWV is decreased whereas threshold
values >13% variation still retain their positive predictive
value. Third, marked decreases in chest wall compliance
will decrease the positive predictive value of all indices
whereas intra-abdominal hypertension may mask hypo-
volemia but will not alter the volume responsiveness
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acute cor pulmonale, with marked ventricular inter-
dependence, one will see a paradoxical positive SPV,
PPV, SVV, or PWV which will increase more with fluid
resuscitation. Thus, when dynamic indices are utilized
for guiding fluid therapy, some measure of the effective-
ness of augmented perfusion should be considered.
Importantly, if these indices have values >20%, then
the subject is clearly volume responsive. However, values
from 9% to 13% may represent a ‘gray zone’ with less posi-
tive and negative predictive values and greater patient-to-
patient variability. In these cases and when any of the
above limitations precludes the use of these parameters,
one may consider performing a fluid challenge or passive
leg raising (PLR) maneuver [101]. In contrast to a mechan-
ical breath that normally reduces CO, the PLR causes an
‘endogenous fluid challenge’ which will increase CO in ‘re-
sponders’. The PLR maneuver with a sensitivity of 89.4%
and a specificity of 91.4% for predicting volume responsive-
ness is best coupled with minimally invasive cardiac output
monitors that can track changes in stroke volume and
cardiac output dynamically and in real time regardless
of the mode of ventilation [102,103]. The execution of
PLR, however, necessitates a major positional change,
which generally makes it impractical for intraoperative
use. However, there are instances in the operating room
(OR) where postural changes may induce a hemodynamic
response that may serve as a diagnostic maneuver of fluid
responsiveness.
We recommend that dynamic parameters be used as
an integral part of GDT protocols. The limitations of
each dynamic index must be taken into consideration as
well as the concept of a gray zone. Dynamic parameters
neither provide a measure of fluid bolus effectiveness nor
should they to be used as an indication to give fluids.
The final decision to administer fluids must be supported
by the apparent need for hemodynamic improvement, the
presence of fluid responsiveness, and the lack of associ-
ated risk.
Composition of fluid therapy: crystalloids and colloids
There has been extensive research evaluating the risks and
benefits of specific types of fluids and developing alterna-
tive solutions that restore effective circulatory volume and
enhance microcirculatory flow. Despite all these efforts,Table 2 Commonly applied crystalloid solutions: osmolality, c
Fluid Osmolality (mOsm/l) pH Na+ (mEq/l) K+ (mEq/l
Plasma 285 to 295 7.4 142 4
0.9% saline 308 5.5 154
Lactate Ringer’s 273 6.5 130 5.4
Plasmalyte 294 7.4 140 5the ideal resuscitation fluid or combination of fluids re-
mains undefined.
There are three fluid categories - crystalloids, colloids,
and blood. Each has its unique characteristics and role
in fluid therapy. This discussion will focus on crystalloid
and colloid therapy.
 Crystalloids are electrolyte solutions which are best
used to replace extracellular volume losses from
perspiration, respiration, and urine output. Although
crystalloids increase vascular volume and may
improve hemodynamics, the effectiveness is
transient and less than colloid solutions. Crystalloids
can be classified by their composition and
osmolality. Normal saline (NS) is slightly hypertonic
at 308 mOsm/l, and lactated Ringer’s (LR) is slightly
hypotonic at 273 mOsm/l comparing to plasma
osmolality. Plasmalyte is the most balanced isotonic
electrolyte solution and has an osmolality of
294 mOsm (Table 2).
 Colloids are solutions of macromolecular solutes
that exert a colloid osmotic pressure across the
microvascular tissue barrier and retain fluid in the
intravascular bed. Colloids efficiently increase
vascular volume, preload, cardiac output, and tissue
perfusion in volume responsive patients. Many of
the GDT trials that have shown improved outcomes
employ the use of iterative infusions (small volume
boluses) of colloid (Table 1) [23,29-59]. Compared
with the hemodynamic and volume-restoring effects
of crystalloid therapy, equi-efficacious volumes
of colloid are smaller; thus, colloid use may be
considered an approach to limiting total volumes,
which may contribute to better outcomes.
Comparison with the plasma composition. Commonly
used intravenous fluids vary considerably in osmolality,
ionic composition, and pH. Crystalloid selection should
be based upon individual patient need with clinical con-
sideration of these components.
The choice of fluids is largely based on traditional
beliefs, context of practice, location [104], and cost. For
example, in comparing the use of colloid to crystalloid
for treating hypovolemia, clinicians from the UK, China,
and Australia rely primarily on colloid therapy (55% toationic, and anionic composition
) Ca++ (mEql/l) Lactate (mEql/l) Cl− (mEq/l) Acetate (mEq/l)
5 27 1
154
2.7 29 109
98 27
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use colloid for treating hypovolemia [105].
Results of clinical trials comparing fluid resuscitation
with colloids and crystalloids in different populations have
been conflicting. Most recently, as highlighted in clinical
trials and meta-analyses, the safety of using specific col-
loids (starches) for fluid resuscitation has been questioned
[106,107]. Table 3 shows the main current concerns re-
garding specific crystalloids and colloids [108-114].
The CRISTAL trial compared the effects of fluid resus-
citation with colloids versus crystalloids on mortality in
patients admitted to the ICU with hypovolemic shock.
There was no difference in 28-day mortality between pa-
tients resuscitated with crystalloids or colloids. However,
the 90-day mortality was significantly reduced in patients
treated with colloids [115]. On the other hand, in patients
with severe sepsis and capillary leakage, the fluid-sparing
effect of colloids appears to be smaller than anticipated
[112,113]. However, balancing the CRISTAL trial, the re-
cently completed ALBIOS trial comparing 20% albumin
and crystalloid versus crystalloid in 1,818 septic patients
demonstrated that the colloid group had a higher mean
arterial pressure during the first 7 days whereas there were
no differences in the total amount of fluids administered
between the two groups and both 28-day and 90-day mor-
tality rates were similar. Thus, there is no compelling evi-
dence that adding colloids to fluid resuscitation materially
alters clinically relevant outcomes [116].
Given the evidence of harm and lack of significant clin-
ical benefit in critically ill patients, when considering the
administration of synthetic colloids, the anesthesiologist
should first assess patient-specific risk. There is no evi-
dence that the deleterious effects of starch-based colloids
occur with albumin. The beneficial hemodynamic effects
of colloid in GDT groups versus standard of care therapy
suggest benefit of nonstarch colloids such as albumin. It
should be noted that the deleterious effects of starches
have largely been reported in ICU trials where starch ther-
apy was used for multiple days. In contrast, the beneficial
effects of perioperative GDT trials that included starch-
based volume therapy were only of limited duration andTable 3 Main current concerns regarding the use of specific c
Solution Concerns
Normal saline Hyperchloremic acidosis
Reduction of renal perfusion
Starch solutions Acute kidney injury and increased requirement of
replacement therapy
Increased mortality
Increased need for PRBC transfusion
Results of clinical trials comparing fluid resuscitation with colloids and crystalloids in
concerns regarding specific crystalloids and colloids.thus exposure. For this reason, we cannot conclude that
the deleterious effects of starches shown in the ICU popu-
lation are generalizable to the limited use that occurs in
the immediate surgical space. Serious thought to the indi-
vidual surgical patient’s co-morbidities, especially acute
kidney injury, can inform the anesthesiologist of potential
increased risk of starch-based colloid therapy.
A recent Cochrane meta-analyses has concluded, how-
ever, that there is no evidence from randomized clinical
trials that resuscitation with colloids, instead of crystal-
loids, reduces the risk of death in patients with trauma,
burns, or following surgery [117]. Common to all meta-
analyses and systematic reviews, inclusion of studies whose
interventions and patient characteristics are often insuffi-
ciently comparable and, therefore, the calculation of a
summary effect measure may be questioned. The resuscita-
tion regimen, the type of colloid or crystalloid, and the end
points that guided resuscitation differed between trials.
Further, the value of colloids when used as part of GDT
may be apparent only in high-risk surgery patients.
Similar caution and approach should be applied to other
synthetic colloids such as dextran and gelatin. Scant clin-
ical evidence exists as to either benefit or harm regarding
to the administration of other colloid solutions such as
dextran or gelatin to surgical patients. Siting theoretical
safety concerns, some authors posit caution for the rou-
tine use of these fluids in surgical patients [117]. It should
not be assumed that results from fluid resuscitation trials
in ICU populations apply to surgical patients. Properly
powered, prospective trials comparing different fluids in
defined patient populations undergoing specific surgical
procedures are needed [118].
We recommend crystalloid solutions for routine sur-
gery of short duration. However, in major surgery, the
use of a goal-directed fluid regimen containing colloid
and balanced-salt solutions is recommended. Though a
black box warning for the use of starch solutions exists
within the US, there is limited data relative to their
harm in the perioperative space. Careful consideration
should occur in patients with known renal dysfunction
and/or sepsis prior to administering starch solutions.rystalloids and colloids
Literature
Hyperchloremia after noncardiac surgery is independently
associated with morbidity and mortality [108]
May contribute to acute renal injury [109,110]
renal Critically ill septic patients [111-114]
Critically ill septic patients [112,114]
Critically ill septic patients [114]
different populations have been conflicting. This table summarizes current
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Disagreement about optimal perioperative fluid therapy is
exacerbated by the lack of uniform definitions for stand-
ard, restrictive, and supplemental fluid delivery [21]. This,
in turn, hinders comparisons of published studies [119].
Better definitions of the fluid regimen will help facility
champions to develop local guidelines and algorithms.
Guidelines are general suggestions of care based on
principles extracted from evidence-based findings and
consensus. Algorithms are highly specific as to the variable
(s) used, their target values, and their specific steps.
The difference between a guideline and an algorithm
is important. Guidelines do not provide sufficient detail
to reduce variation of care. Two anesthesiologists could
strictly adhere to a guideline, but their specific fluid therapy
delivered to an identical patient could be quite different.
Even one of these individual anesthesiologist’s practices for
two identical patients could differ from 1 day to another.
Improved outcomes, reduced readmissions, and reduced
costs have resulted when quality improvement programs
have been implemented to reduce variability [120,121].
The implementation of algorithms or detailed protocols
into routine anesthetic care is far more important than ad-
herence to guidelines when attempting to reduce clinical
variation. Enhanced recovery after surgery (ERAS) proto-
cols represent multidisciplinary perioperative care path-
ways that seem to be associated with significant reductions
of the surgical stress response, complications, and hospital
length of stay (HLOS) [122,123]. A recent clinical trial
showed that the implementation of an ERAS protocol for
colorectal surgery at a tertiary medical center was associ-
ated with a significant reduction of HLOS for both open
and laparoscopic colorectal surgeries. The authors, how-
ever, were not able to show significant difference in the
total medical costs for patients in the ERAS pathway versus
the traditional care group [124]. Importantly, fluid therapy
was only one of the 23 steps that were implemented within
the study protocol. Unfortunately, we are unable to define
the impact of this critical step as the study was not de-
signed to do so. It is likely that some interventions are
more important than others relative to reducing complica-
tions, readmissions, and total hospital costs, and some may
be nonessential. Indeed, Loftus et al. demonstrated that
significant reductions in complications and readmissions
could be realized with the implementation of a simple two-
step ERAS protocol focusing on early ambulation and ali-
mentation following colorectal surgery [121].
Importantly, algorithms should not be fixed, they should
allow for individualizing fluid therapy based on changing
physiologic need and response to fluid and drug therapy.
Algorithms can become very detailed and are likely to be
best implemented with computerized decision support
[125,126]. Both guidelines and algorithms can be displayed
in flow chart format or computerized. Figure 2 providesan example of fluid therapy algorithm [58]. There will be
many perioperative events that require deviation from al-
gorithms. There is no substitute for medical training and
expertise; however, deviation from any protocol should
have a rational basis. Furthermore, nonadherence is often
an opportunity to better understand and improve guide-
lines and algorithms.
Computerized decision support and implementation of
closed-loop fluid administration has been described. Sig-
nificant regulatory challenges exist before these systems
can be introduced into clinical practice [127,128]. Re-
cently, the first clinical use of a closed-loop fluid man-
agement system was reported [129]. With this approach,
91% of the physiologic targets were obtained. The authors
suggest that the use of a closed-loop fluid management
system may ease the implementation of algorithms, in-
crease compliance with best practices, and relieve clini-
cians from time-intensive repetitive tasks [128].
We recommend the use of algorithms as part of the
perioperative fluid plan. These should be available and
easily accessible within all operating rooms. We encourage
continued development, refinement, and testing of comput-
erized decision support tools.
The perioperative fluid plan
The use of protocols for perioperative hemodynamic sup-
port which enhance tissue perfusion has been shown in
multiple meta-analyses to reduce organ dysfunction, mor-
tality, and HLOS [7,10,130,131]. These outcomes are espe-
cially evident when applied to the sickest patients [132]. A
fundamental aspect in any perioperative protocol is the
use of a fluid therapy plan that should be centered on
physiological principles, evidence-based medicine, and
local expertise. Given the absence of an internationally
accepted fluid protocol or comprehensive fluid therapy,
guidelines creating local standards become imperative.
The anesthesiologist should have an individualized peri-
operative fluid optimization and hemodynamic moni-
toring plan for each surgical patient based upon the
following:
1) Patient status (health, age, physiology, and
co-morbidities);
2) Surgical risk (procedure, approach, and surgical
expertise);
3) Selection of hemodynamic monitoring based upon
patient and surgical risk as well as the
anesthesiologists’ clinical management needs
(continuous blood pressure, cardiac performance,
volume responsiveness, acid-base management,
optimize oxygenation and ventilation, central venous
and/or pulmonary artery pressures, central or mixed
venous oxygenation). Figure 3 shows a rational
approach to intraoperative monitoring.
Figure 2 Goal-directed hemodynamic algorithm to guide intraoperative volume therapy in major abdominal surgeries: (a) initial
assessment and treatment and (b) further intraoperative optimization [58] (used per BioMed Central’s creative commons license).
PPV, pulse pressure variation; CI, cardiac index; MAP, mean arterial pressure.
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posed key principles regarding hemodynamic monitoring.
Some of these principles are summarized in Table 4. In
summary, the best choice for monitored variables depends
on the type of patient, the question being asked, and the
condition being managed or anticipated (Figure 3). It is
crucial to understand that it is not the monitoring itself
that can improve outcomes, but the changes in therapyguided by the data obtained [133,134]. Advantages of non-
invasive or minimally invasive approaches are obvious.
Further considerations of specific monitors are beyond
the scope of this review.
In low-risk patients and low-risk surgery, the use of
ASA standard monitors is often sufficient. However, if the
associated risk or surgical procedure escalates, or if unex-
pected patient instability develops, additional expertise
Figure 3 A rational approach to intraoperative monitoring. A useful approach for assessing the needed level of hemodynamic monitoring
based on the patient status, surgical risk, and clinical management requirements (what are my management needs?). NIBP, noninvasive blood
pressure; ECG, electrocardiogram; A-line, arterial catheterization; NICP, noninvasive continuous pressure; CVC, central venous catheter; ECHO,
transthoracic or transesophageal echocardiography; PAC, pulmonary artery catheter; ScVO2, central venous oxygen saturation; MVO2, mixed
venous oxygen saturation; PCA, pulse contour analysis; BioImp, bioimpedance or bioreactance.
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itoring is not without increased risk and cost; thus, these
tools should only be applied when needed to provide a
means to better detect and treat tissue mal-perfusion and
potential organ dysfunction. Fluid therapy is a corner-
stone for perioperative medicine, but clarity on when
not to infuse fluids is as important as when to infuse.
Hemodynamic and other advanced monitoring is often
the best means to assess and assure the optimization of
intravascular volume, pressure, perfusion, and oxygenation.
Invasive cardiovascular monitors can be considered in
patients in whom tight hemodynamic control is needed
to prevent rapid organ deterioration, for example, signifi-
cant heart or brain disease and in high-risk surgical cases,
for example, aortic and heart surgery. Indices from com-
monly used invasive monitors include intra-arterial pres-
sure from an arterial catheter, right and left heart fillingTable 4 Principles of hemodynamic monitoring (Vincent et al
Principle Rational
No hemodynamic monitoring technique can improve
outcome by itself
If the data ar
will not impr
Monitoring requirements may vary over time Optimal mon
present or p
monitoring t
There are no optimal hemodynamic values or targets
that are applicable to all patients
Targets and
Any variable on its own provides just one piece of a
large puzzle
Variables sho
Continuous measurements of hemodynamic variables
is preferable
Real time inf
This table highlights a fundamental truth regarding hemodynamic monitoring and
outcomes unless coupled to treatments or treatment protocols which are known topressures, and central or mixed venous oxygenation sat-
urations from central venous or pulmonary artery cath-
eters, respectively.
There are several commercially available noninvasive
or minimally invasive technologies that employ arterial
pulse contour analysis, bioimpedance, or bioreactance and
which provide continuous cardiac output, dynamic indices,
and systemic vascular resistance. Finally, echocardiography,
transthoracic and transesophageal (TEE), is becoming in-
creasingly utilized in at risk patients. Mastering cardiac
performance and volume assessment by TEE may improve
currently available GDTalgorithms.
We recommend that a perioperative fluid plan be de-
veloped by each department, facility, or health system
and used by all anesthesiologists. Clinical needs, inva-
siveness, accuracy, and precision of available technologies
should be considered when selecting monitoring devices..) [133]
e interpreted or applied incorrectly the resultant change in management
ove patient outcome and may be deleterious
itoring system depend on the individual patient, the problem already
otentially arising, and the devices and expertise available. Different
echniques can sometimes be used to complement each other.
alarms should thus be individualized and reassessed regularly
uld be combined and integrated
ormation and trends are useful on the perioperative settings
patient outcomes: Hemodynamic monitoring devices do not change patient
improve outcome.
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Until recently, perioperative fluid replacement was
guided primarily by estimates of known or anticipated
fluid deficits and replacing these using fixed calculations
for administration of intravenous fluid. Little outcome
data exist that support the widespread use of fixed peri-
operative fluid regimens. Recent approaches have focused
attention on the type of surgery being performed and the
impact of the following outcomes: 1) the type of fluid be-
ing administered; 2) the timing of fluid administration; 3)
the rate of fluid administration [135,136]; 4) the total
amount of fluid administered; and 5) the best measures
to both optimize and individualize perioperative fluid
therapy [64].
Effective fluid therapy algorithms incorporate GDT.
Table 1 lists trials of GDT for specific surgical procedures
and the target goals and algorithms employed and their
impact on outcomes. Algorithms should incorporate strat-
egies and clinical pathways for patients who do not respond
to fluid therapy (‘nonresponders’) and co-morbidities.
There are two overall challenges for fluid optimization
as follows: 1) how to best identify hypovolemia and
tissue hypoperfusion; and 2) how to best optimize vascu-
lar volume, cardiac filling, global, and regional perfusion
and tissue oxygenation.
Identifying the need for hemodynamic support The
most common parameters that are used to guide the
need for hemodynamic support and perioperative fluids
include clinical experience, urinary output, mean arterial
pressure, and CVP [62,137]. Other variables that may be
available include cardiac output, systemic vascular resist-
ance, serum lactate, and central or mixed venous oxygen
saturation. Peripheral pulses, skin temperature, appear-
ance, and turgor are subjective measures that require
significant clinical experience and acumen to be used ef-
fectively. The response of the CO to fluid administration
depends on the preload status and on the contractile state
of the heart, namely the slope of both the RV and LV func-
tion curve [138]. This explains why some hemodynamic
variables, for example, central venous pressure, can fail to
predict the response of the CO to fluid administration
[65,79,139-141]. Only half (!) of critically ill and high-risk
surgical patients, in whom fluid loading seems to be in-
dicated, do indeed increase their CO in response to fluid
loading (‘responders’), while the other half (‘nonre-
sponders’) can be loaded with fluids unnecessarily [72].
When making a decision about fluid administration, it
is best to rely on the assessment of fluid responsiveness,
that is, a measure of the change in CO in response to an
increase in preload [142] as discussed below. The re-
cently completed OPTIMISE trial when coupled with a
meta-analysis of prior clinical trials demonstrated that
using cardiac output targets to guide intraoperative fluidresuscitation decrease postoperative complications and
reduce hospital length of stay [59].
Controversies within the GDT literature Although the
goal-directed fluid therapy concept was first suggested
more than 30 years ago [143], there remains no consensus
about the most effective goals for fluid therapy or the most
appropriated monitoring methods. As such, despite evi-
dences demonstrating potential benefit of this technique in
several disease states [144], GDT remains a well-accepted
concept that has not yet translated to an established stand-
ard of care [145]. As exemplified in Table 1, directed com-
parison between studies is hampered by the large range of
goals and methods for monitoring the inconsistency of
study designs and the lack of common control groups
[145]. Accordingly, there is an urgent need to address this
research gap, providing high-quality evidence in support to
different goals and methods of monitoring fluid therapy.
While the benefits of perioperative goal-directed fluid
therapy have yet to be proven, the bulk of clinical research
supports the implementation of a two-step GDT plan which
is to begin immediately after induction of anesthesia. First,
determine if the patient requires hemodynamic support or
augmentation of cardiovascular function. Second, if the
need is apparent and the patient is fluid responsive, fluid
bolus therapy should be considered and guided by contin-
ual, and if available continuous, assessment of fluid respon-
siveness as described below.
The fluid challenge
A fluid challenge is one of the best tools that the
anesthesiologist has for assessing fluid responsiveness.
To test fluid responsiveness, a change in preload (fluid
bolus) must be induced while monitoring the subse-
quent change in stroke volume, cardiac output, and dy-
namic indices [146].
The use of a fluid bolus provides two advantages as
follows:
1) a means to assess the patient’s response to fluid with
changes in dynamic indices and static indices of
volume, flow, and oxygenation;
2) a prompt increase in intravascular volume and
usually a needed improvement in flow (cardiac
output).
A fluid bolus is a provocative test of the circulation,
similar to the use of a step function in engineering to
define a system. The use of a ‘test’ that uses a small
amount of fluid (bolus) to assess the volume responsive-
ness may reduce the risk of a too liberal fluid strategy
and the possible consequences of fluid overload. These
tools help to determine the requirements for additional
fluid therapy avoiding the deleterious consequences of
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ministration [147].
It is important to stress that the fluid challenge tech-
nique is a test of the cardiovascular system. It allows cli-
nicians to assess whether a patient has enough preload
reserve to increase stroke volume with further fluids.
Fluid therapy should be considered after a positive re-
sponse to a fluid challenge. In contrast to a single fluid
challenge, fluids can also be infused in a controlled fashion
based on an algorithm by repeating the fluid challenge as
long as there is a positive response. This controlled ap-
proach is called stroke volume maximization and is the
cornerstone of most goal-directed therapy protocols [38].
Thus, the only reason to perform a fluid challenge is to in-
crease a patient’s stroke volume; if this does not happen,
further fluid administration is likely to be harmful [148].
A fluid challenge should comprise four separate or-
ders: the type of fluid to be infused, the volume of fluid
to be infused, the rate of the infusion, and the stopping
rules if untoward effects are seen before the full amount
of the bolus is infused. For rapid infusions of very small
boluses of fluid (for example, 250 ml crystalloid over 1
to 2 min), stopping rules are probably not necessary. But
if larger amounts of fluids or longer infusion times are
used, clear stopping rules are important to prevent right
heart failure or pulmonary edema.
Although no consensus is available for the type and
exact dosing of fluid administration, boluses are best de-
livered at a rapid rate (5 to 10 min) with prompt assess-
ment of the physiologic response. The magnitude of this
response helps to determine the effectiveness of the fluid
challenge as well as the requirements for additional fluid
therapy. Taken together, this approach avoids the dele-
terious consequences of fluid overload [147]. The peak
and sustainment of improvement in dynamic and static
variables after a fluid bolus is dependent on both the
physiologic state and fluid composition. Moreover, sus-
tainment of the response after bolus can be reduced in
the presence of continuing hemorrhage.
Establishing volume status is complex, making accur-
ate prediction of an increase in stroke volume upon fluid
load challenging. However, under conditions of hypovol-
emia and inadequate perfusion, there is greater vascular
retention of infused volume due to physiologic compen-
satory mechanisms that act to maintain normal volume,
pressure, and perfusion. These compensatory mechanisms
include the renal response to elevated vasopressin, angio-
tensin, and aldosterone; reduced capillary filtration due to
reduced venous and capillary pressures; and decreased ca-
pillary hydraulic conductivity due to fluid composition
and decreased levels of atrial natriuretic peptide (ANP)
[149,150]. The use of a limited selection of specific vol-
umes and delivered at set rate(s) of infusion provides a
standardized test for volume responsiveness and a bettermeans for the comparative assessment of changes in vol-
ume responsiveness.
We recommend bolus therapy rather than continuous
infusion when the goal is to improve pressure, perfusion,
and oxygen delivery. Standardization of the fluid bolus
relative to fluid composition, volume, infusion rate, and
time to post bolus assessment should be implemented. The
variables used for assessing the effectiveness of the fluid
bolus should include appropriate changes in cardiac out-
put or stroke volume.
Maintenance fluids
Traditional perioperative fluid administration is guided
by estimates of both the preoperative fluid deficit and by
ongoing sensible and insensible intraoperative fluid losses.
The notion that all surgical patients are hypovolemic due
to prolonged fasting, bowel preparation, and ongoing losses
from perspiration and urinary output is unfounded. Pre-
operative volume status is typically unknown and should
not be presumed to be either adequate or inadequate.
Blood volume varies considerably between patients de-
pending on gender, weight, and oxygen consumption
[151-153]. Moreover, effective circulatory volume varies
when patients are under anesthesia [154]. Furthermore,
our understanding of fluid shifting has changed and the
so-called ‘third space’ has mostly been abandoned [155].
Additionally, perioperative deficits and insensible losses
are often overestimated. Almost 40 years ago, direct mea-
surements of basal evaporation rate from skin, airway and
large exposure of bowel showed that fluid loss is 0.5 to
1.0 ml/kg/h during major abdominal surgery [156]. Des-
pite this fact, many current textbooks and guidelines for
perioperative fluid management in major abdominal sur-
gery suggest large amounts of crystalloids (5 to 7 ml/kg/h)
for maintenance of intraoperative circulating volume [6].
The majority of the patients present with a minor func-
tional intravascular deficit before surgery (200 to 600 ml)
that is unlikely to have clinical significance [7]. This may
explain why prophylactic fluid boluses have no major ef-
fects on the incidence or severity of anesthesia-related
hypotension [157]. Research has shown that fasting from
solid food for 6 h and fluids for 2 h prior to surgery is safe
and improves outcomes compared with longer fasting pe-
riods [122]. Moreover, mechanical bowel preparation before
elective abdominal surgery has been strongly challenged.
Indeed, current ERAS guidelines discourage bowel prepar-
ation routinely for colonic surgery [122].
In the clinical context of ambulatory surgery in low-
risk patients, a more liberal fluid strategy may be benefi-
cial. Up to 20 to 30 ml/kg/h of crystalloid infusion
reduces postoperative dizziness, drowsiness, pain, nau-
sea, vomiting, and hospital length of stay [158-160]. To
the contrary, studies of patients undergoing major sur-
gery may favor a more restrictive fluid regime [17,24],
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fluid overloading significantly increases interstitial edema
[161]. Because microvascular permeability peaks at 3 to
4 h after surgical injury [162], lengthy procedures are
thus associated with capillary leakage and enhanced
edema formation.
We recommend that maintenance fluids be adminis-
tered at a rate of 1 to 2 ml/kg/h for patients undergoing
procedures of longer duration or magnitude. Patients
undergoing outpatient procedures may benefit from higher
maintenance fluid rates.Conclusions
Although perioperative fluid management remains a
highly debated subject, data suggests that goal-directed
fluid therapy with the objective of hemodynamic
optimization can reduce complications after major sur-
gery. Specific hemodynamic goals include maintaining
adequate circulating volume, perfusion pressure, and
oxygen delivery. Lack of standard criteria for periopera-
tive fluid therapy results in significant clinical variabil-
ity relative to its administration.
In summary, fluids should be treated as any other intra-
venous drug therapy, and thus, careful consideration of its
timing and dose is mandatory. A perioperative fluid plan
should be developed which is easily understood and used
by all anesthesiologists within a group, facility, or health-
care system. Determining both the need for augmented
perfusion and fluid responsiveness is fundamental when
making fluid therapy decisions to avoid unjustified fluid
administration. Balanced crystalloid solutions should be
given for short duration/low-risk surgical patients. Pro-
cedures of higher complexity are best managed with a
combination of crystalloid and colloid therapy. When
considering the administration of starch containing
solutions, the anesthesiologist should first assess patient-
specific risk. Finally, we recommend the use of algorithms
as part of the perioperative fluid plan.
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